Kurt et al. reported that pentraxin 3, a novel inflammation biomarker and CRP level, did not differ between COPD A-D groups.16 But in that study, the number of patients in each group was only 8, 13, 2 and 24 respectively. Here, PTX3 is linked to chronic obstructive pulmonary disease.